Delivery Order SPE2DB22D1202-SPE2DB25FVFU0
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,438.08 for methylphenidate ER 36 mg tablets (100-count supply) on July 22, 2025, with ultimate completion by July 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Methylphenidate ER 36 mg tablets (100 count) with a ceiling value of $2,544.82. This is a firm fixed-price delivery order with no set-aside designation, executed competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion through December 2026. The product will be delivered to the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Methylphenidate ER 36 mg tablets (100 count) with a firm fixed price of $1,260.63. This non-set-aside, competitively awarded contract is classified as a delivery order under a larger indefinite delivery contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor for federal medical procurement and is a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count packages) with a contract value of $2,196.52. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively determined. The order is scheduled for completion by July 23, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $1,043.04 to AmerisourceBergen Drug Corp for Methylphenidate ER 36 mg tablets (100 count) on July 22, 2025, with a completion date of July 23, 2025. This non-set-aside, firm fixed price delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,512,599 units of Methylphenidate ER 18 mg tablets in 100-count bottles. The $1,263.10 contract has a completion date of February 2, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which falls under a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded by...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,776.91 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4563927900 - Methylphenidate ER 36 mg Tablets in 100-count packages. The contract has an ultimate completion date of March 12, 2024. AmerisourceBergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,682.51 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,566,177,514 units of Methylphenidate ER 27 mg tablets. The contract has an ultimate completion date of October 23, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,649.02 to AmerisourceBergen Drug Corp for Methylphenidate ER 54 mg tablets (100-count units) on July 24, 2025, with completion targeted for July 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,398,454 units of Methylphenidate ER 36 mg tablets. The $3,685.91 delivery order was issued under an existing contract and has a completion date of January 23, 2024. Amerisourcebergen Drug Corp, as a prime contractor, has previously provided a range of pharmaceutical products and medical supplies to...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVFU0Delivery Order
The Defense Logistics Agency (DLA) awarded a $1,479.44 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Methylphenidate ER 36 mg tablets in a quantity of 100 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime pharmaceutical supply vehicle enables the company to furnish a comprehensive range of generic and brand-name medications, vaccines, and medical supplies to support military healthcare programs globally. AmerisourceBergen's consistent receipt of competitively awarded delivery orders through this contract vehicle demonstrates the company's established capability to meet federal medical procurement requirements across diverse therapeutic domains for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 7/28/25 |